JPWO2020223445A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020223445A5 JPWO2020223445A5 JP2021564537A JP2021564537A JPWO2020223445A5 JP WO2020223445 A5 JPWO2020223445 A5 JP WO2020223445A5 JP 2021564537 A JP2021564537 A JP 2021564537A JP 2021564537 A JP2021564537 A JP 2021564537A JP WO2020223445 A5 JPWO2020223445 A5 JP WO2020223445A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- amino acid
- acid sequence
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962841128P | 2019-04-30 | 2019-04-30 | |
| US62/841,128 | 2019-04-30 | ||
| US201962854151P | 2019-05-29 | 2019-05-29 | |
| US62/854,151 | 2019-05-29 | ||
| US201962893106P | 2019-08-28 | 2019-08-28 | |
| US62/893,106 | 2019-08-28 | ||
| PCT/US2020/030640 WO2020223445A1 (en) | 2019-04-30 | 2020-04-30 | Chimeric receptors and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022530542A JP2022530542A (ja) | 2022-06-29 |
| JPWO2020223445A5 true JPWO2020223445A5 (ru) | 2023-05-01 |
Family
ID=73029309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564537A Pending JP2022530542A (ja) | 2019-04-30 | 2020-04-30 | キメラ受容体及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3962527A4 (ru) |
| JP (1) | JP2022530542A (ru) |
| KR (1) | KR20220016083A (ru) |
| CN (1) | CN114007642A (ru) |
| AU (1) | AU2020265679A1 (ru) |
| CA (1) | CA3133333A1 (ru) |
| IL (1) | IL287407A (ru) |
| SG (1) | SG11202111130SA (ru) |
| TW (1) | TW202110873A (ru) |
| WO (1) | WO2020223445A1 (ru) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220289842A1 (en) * | 2019-08-20 | 2022-09-15 | Senti Biosciences, Inc. | Chimeric inhibitory receptor |
| IL302728A (en) * | 2020-11-13 | 2023-07-01 | Catamaran Bio Inc | Genetically modified natural killer cells and methods of using them |
| WO2022115565A2 (en) * | 2020-11-24 | 2022-06-02 | Senti Biosciences, Inc. | Chimeric receptors and methods of use thereof |
| US11661459B2 (en) | 2020-12-03 | 2023-05-30 | Century Therapeutics, Inc. | Artificial cell death polypeptide for chimeric antigen receptor and uses thereof |
| JP2024500847A (ja) | 2020-12-18 | 2024-01-10 | センチュリー セラピューティクス，インコーポレイテッド | 適合可能な受容体特異性を有するキメラ抗原受容体システム |
| EP4334346A2 (en) * | 2021-05-07 | 2024-03-13 | Senti Biosciences, Inc. | Chimeric receptors and methods of use thereof |
| AU2022324040A1 (en) | 2021-08-04 | 2024-02-22 | The Regents Of The University Of Colorado, A Body Corporate | Lat activating chimeric antigen receptor t cells and methods of use thereof |
| CN113980907B (zh) * | 2021-12-24 | 2022-03-15 | 山东兴瑞生物科技有限公司 | 一种抗flt3嵌合抗原受体修饰的t细胞及其在制备治疗aml药物中的应用 |
| CN114645022B (zh) * | 2022-05-13 | 2022-09-02 | 首都医科大学宣武医院 | 靶向CD5的CAR-γ δ T细胞及其制备方法与应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2322547A1 (en) * | 2003-06-25 | 2011-05-18 | Crucell Holland B.V. | Myeloid cell-specific lectin |
| AR071891A1 (es) * | 2008-05-30 | 2010-07-21 | Imclone Llc | Anticuerpos humanos anti-flt3 (receptor tirosina cinasa 3 tipo fms humano) |
| CA3060520C (en) * | 2012-10-12 | 2022-05-17 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| EP4205749A1 (en) * | 2014-07-31 | 2023-07-05 | Novartis AG | Subset-optimized chimeric antigen receptor-containing cells |
| US11655452B2 (en) * | 2015-06-25 | 2023-05-23 | Icell Gene Therapeutics Inc. | Chimeric antigen receptors (CARs), compositions and methods of use thereof |
| AU2017279548A1 (en) * | 2016-06-08 | 2018-12-13 | Precigen, Inc. | Cd33 specific chimeric antigen receptors |
| EP3474867A4 (en) * | 2016-06-24 | 2020-05-20 | iCell Gene Therapeutics LLC | CHIMERIC ANTIGEN (CAR) RECEPTORS, COMPOSITIONS AND RELATED METHODS |
| AU2018288814A1 (en) * | 2017-06-21 | 2020-02-06 | Icell Gene Therapeutics Llc | Chimeric antigen receptors (CARs), compositions and methods thereof |
| CA3071303A1 (en) * | 2017-08-01 | 2019-02-07 | Julius-Maximilians-Universitat Wurzburg | Use of flt3 car-t cells and flt3 inhibitors to treat acute myeloid leukemia |
| AU2018347601A1 (en) * | 2017-10-12 | 2020-04-23 | Icell Gene Therapeutics, Llc | Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof |
-
2020
- 2020-04-30 CN CN202080041163.8A patent/CN114007642A/zh active Pending
- 2020-04-30 TW TW109114659A patent/TW202110873A/zh unknown
- 2020-04-30 EP EP20798134.1A patent/EP3962527A4/en active Pending
- 2020-04-30 AU AU2020265679A patent/AU2020265679A1/en active Pending
- 2020-04-30 JP JP2021564537A patent/JP2022530542A/ja active Pending
- 2020-04-30 KR KR1020217039056A patent/KR20220016083A/ko unknown
- 2020-04-30 CA CA3133333A patent/CA3133333A1/en active Pending
- 2020-04-30 WO PCT/US2020/030640 patent/WO2020223445A1/en active Application Filing
- 2020-04-30 SG SG11202111130SA patent/SG11202111130SA/en unknown
-
2021
- 2021-10-19 IL IL287407A patent/IL287407A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10793638B2 (en) | Use of chimeric antigen receptor modified cells to treat cancer | |
| JP6919091B2 (ja) | Ｇタンパク質共役受容体を標的化するキメラ抗原受容体およびその使用 | |
| US20230140802A1 (en) | Novel platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy | |
| US9828425B2 (en) | Anti-ILT5 antibodies and ILT5-binding antibody fragments | |
| DE69433820T2 (de) | Verwendung von löslichen oligomerischen cd40 liganden oder monoklonalen antikörpern zur herstellung eines arzneimitells zur vorbeugung oder behandlung von neoplastischen krankheiten | |
| JP2021535756A (ja) | 単一ドメイン抗体に基づくｂｃｍａキメラ抗原受容体及びその使用 | |
| KR20190034588A (ko) | 키메라 항원 수용체 및 pd-1 억제제의 조합 요법 | |
| US9534051B2 (en) | Immunoregulation by anti-ILT5 antibodies and ILT5-binding antibody fragments | |
| JP2017537629A5 (ru) | ||
| JP2020530989A5 (ru) | ||
| CA3032146A1 (en) | Identification of vsig3/vista as a novel immune checkpoint and use thereof for immunotherapy | |
| JP2018533371A5 (ru) | ||
| US11840575B2 (en) | Engineered immune cells targeting BCMA and their uses thereof | |
| JP2019527696A5 (ru) | ||
| CA3177829A1 (en) | Chimeric antigen and t cell receptors and methods of use | |
| JP7358369B2 (ja) | Ｃｄ８３結合キメラ抗原受容体 | |
| JP7252651B2 (ja) | Ｃｄ３３発現がんを標的とするための組成物および方法 | |
| US10654934B2 (en) | Use of chimeric antigen receptor modified cells to treat cancer | |
| JPWO2020223445A5 (ru) | ||
| KR20240037892A (ko) | 클라우딘 18.2 t 세포-항원 커플러 및 이의 용도 | |
| WO2018064921A1 (en) | Use of chimeric antigen receptor modified cells to treat cancer | |
| US20230172923A1 (en) | Methods of treating cytokine-related adverse events | |
| US20210095036A1 (en) | Humanized Anti-GDNF family alpha-receptor 4 (GRF-alpha-4) Antibodies and Chimeric Antigen Receptors (CARs) | |
| CA3228566A1 (en) | Anti-her2 car nk cells, methods of their production and uses thereof | |
| JPWO2021168317A5 (ru) |